High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes

Table 2 Assessment of Relationship between Plasma Lipid, Lipoprotein, Apolipoprotein and HDL Subclasses Contents in CHD Patients with Diabetes

	Preβ₁-HDL	HDL_3c	HDL_3b	HDL_3a	HDL_2a	HDL_{2b+preβ2-HDL}
FPG	.160	.108	.390^*	.398^*	-.570^**	-.630^**
TG	.112	.208	.243^*	.291^*	-.305^**	-.369^**
TC	.099	.199	.192	.210^*	.030	.042
LDL-C	.140	.120	.220^*	.150	-.252^*	-.271^*
HDL-C	.176^*	-.140	-.136	-.174^*	.302^**	.358^**
Gensini Score	.102	.134	.184^*	.211^*	-.234^**	-.263^**
BMI	.210	.231	.217	.256^*	-.244^*	-.270^*
ApoA-I	.430^**	.405^**	.453^**	.507^**	.575^**	.602^**
ApoB-100	.116	.128	.133^*	.101	-.120	-.123
ApoB-100/A-I	.240	.307^*	.365^**	.444^**	-.436^**	-.470^**

CHD, coronary heart disease; FPG, fasting plasma glucose; TG, triglyceride; TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; BMI, body mass index; ApoA-I, apolipoproteinA-I; ApoB-100, apolipoproteinB-100.
^*P < .05, ^**P < .01.

ISSN: 1476-511X